First volunteers receive Rift Valley fever vaccine in Kenya Phase II trial
On 8 July 2025, researchers at the KEMRI-Wellcome Trust Research Programme began the Phase II trial of the ChAdOx1 RVF vaccine in Kilifi, Kenya—the most advanced Rift Valley …
Promising human Rift Valley fever vaccine to enter Phase II clinical ...
Oct 13, 2024 · The launch of a Phase II clinical trial of a Rift Valley fever vaccine candidate in an endemic country is a crucial milestone in our efforts to control this disease.
Consultation on Rift Valley Fever (RVF) research
Oct 31, 2025 · In light of the recent Rift Valley Fever (RVF) outbreak in Senegal and Mauritania, and within the framework of the Phenuiviridae Collaborative Open Research Consortium …
Breakthrough: Rift Valley Fever Vaccine trial begins in Kenya …
Oct 8, 2025 · Researchers at the KEMRI–Wellcome Trust Research Programme in Kilifi have begun the Phase II clinical trial of the ChAdOx1 Rift Valley fever (RVF) vaccine. This marks …
Kenya Launches Rift Valley Fever Vaccine Trial - 18.135.160.37
On July 8, 2025, researchers at the KEMRI–Wellcome Trust Research Programme in Kilifi, in partnership with the University of Oxford, began Phase II clinical trials of the ChAdOx1 RVF …
CEPI-backed trial of Rift Valley fever jab starts in Kenya
Oct 14, 2024 · A promising vaccine candidate for Rift Valley fever (RVF) has been advanced into a phase 2 trial in Kenya, the first time that a shot has reached this stage of development in a …
Timeline for mRNA Vaccine Development for Rift Valley Fever
Jan 23, 2025 · This funding will advance the vaccine candidate through preclinical development and into Phase I clinical trials, with testing planned in South Africa or another outbreak …
A Study to Assess the New Candidate Rift Valley Fever Virus Vaccine …
Feb 6, 2023 · This is a randomised, single blind, placebo-controlled, dose escalation, phase I clinical trial to assess the safety and immunogenicity of the candidate ChAdOx1 RVF vaccine …
Global Experts Launch Sh1.2 Billion Project to Tackle Rift Valley Fever ...
Aug 27, 2025 · In South Africa, Afrigen Biologics is developing the first mRNA-based vaccine for RVF, with nearly $6 million in CEPI support. The vaccine is expected to move into Phase I …